Vimarsana
Biggest News Aggregation in the World

Page 4 - Greg Altman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Altman Today - Breaking & Trending Today

Evolved By Nature Raises $120M Series C, Led by Teachers' Venture Growth, to Scale Sustainable Activated Silk Technology for Global Impact - Vimarsana News

Evolved By Nature Raises $120M Series C, Led by Teachers' Venture Growth, to Scale Sustainable Activated Silk Technology for Global Impact

Biotechnology Company Set to Disrupt Synthetic and Fossil Fuel-Derived Supply Chains in Leather, Apparel and Personal Care with Scale-Up to 900 Metric Tons of Annual Activated Silk Production

Chanel-backed 'activated silk' firm adds new investors - Vimarsana News

Chanel-backed 'activated silk' firm adds new investors

Evolved By Nature, a biotech firm backed by French fashion company Chanel, said on Thursday it has raised $120 million in a financing round, adding new investors including one of Canada's biggest...

Evolved By Nature Closes US 120 Series C Funding - Vimarsana News

Evolved By Nature Closes US 120 Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Evolved By Nature: Evolved by Nature Announces IDE Approval from the FDA to Initiate a Pivotal Clinical Trial for its first Activated Silk Dermal Filler - Vimarsana News

Evolved By Nature: Evolved by Nature Announces IDE Approval from the FDA to Initiate a Pivotal Clinical Trial for its first Activated Silk Dermal Filler

BOSTON, Jan. 12, 2022 /PRNewswire/ -- Biotechnology company Evolved by Nature announced today that sister company Silk Medical Aesthetics has received Investigational Device Exemption (IDE)

Evolved by Nature Announces IDE Approval from the FDA to Initiate a Pivotal Clinical Trial for its first Activated Silk™ Dermal Filler - Vimarsana News

Evolved by Nature Announces IDE Approval from the FDA to Initiate a Pivotal Clinical Trial for its first Activated Silk™ Dermal Filler

BOSTON, Jan. 12, 2022 /PRNewswire/ -- Biotechnology company Evolved by Nature announced today that sister company Silk Medical Aesthetics has received Investigational Device Exemption (IDE) approval from the FDA to initiate a pivotal clinical trial for its new dermal filler for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. The new filler leverages...